Implantica announces positive feedback received from U.S. FDA of the RefluxStop™ PMA Module 2 submission
VADUZ, Liechtenstein, Feb. 13, 2025 /PRNewswire/ — Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including a unique device RefluxStop™ for the treatment of acid reflux, a treatment field with 1 billion sufferers, announces that U.
Outokumpu has decided not to invest in cold rolling capacity expansion in the U.S. at this point of time
Outokumpu Corporation Press release/Investor News February 13, 2025 at 8.50 am EET HELSINKI, Feb. 13, 2025 /PRNewswire/ — On August 3, 2023, Outokumpu communicated that in the next strategy phase, commencing in 2026, the focus will be on strengthening the company’s market position furth
Outokumpu financial statements release 2024 – Full-year adjusted EBITDA EUR 177 million with historically low stainless steel deliveries
HELSINKI, Feb. 13, 2025 /PRNewswire/ — Highlights in Q4 2024 Stainless steel deliveries were 422,000 tonnes (450,000 tonnes)*. Adjusted EBITDA amounted to EUR -3 million (EUR 72 million). EBITDA was EUR -12 million (EUR 15 million). ROCE amounted to -1.2% (-2.1%). Free cash flow was
" title="Based on Two-time winner of the Japan Character Awards Grand Prix, “Chiikawa” The first smartphone app “Chiikawa Pocket” Launching in 43 countries and regions worldwide in late March 2025
TOKYO, Feb. 13, 2025 /PRNewswire/ — Applibot, Inc. (Headquarters: Shibuya, Tokyo; President: Koki Ukita) is launching a smartphone app “Chiikawa Pocket,” in 43 countries and regions worldwide in late March 2025. Based on the popular manga “Chiikawa” posted on X (formerl
Sinch AB: Year-end report, January-December 2024
STOCKHOLM, Feb. 13, 2025 /PRNewswire/ — Focused on the path ahead October – December 2024 Net sales increased by 3 percent to SEK 7,729m (7,532). Gross profit increased by 2 percent to SEK 2,582m (2,526). EBITDA declined by 63 percent to SEK 307m (818) and was negatively affected by a one-ti
DXC Helps European Space Agency Launch GenAI Agents
ASK ESA project uses AI to increase efficiency and share knowledge across major intergovernmental organization ASHBURN, Va., Feb. 13, 2025 /PRNewswire/ — The European Space Agency (ESA) has awarded a contract to DXC Technology (NYSE: DXC), a leading Fortune 500 global technology services provi
Inceptio Technology Spotlighted in ARK Invest Big Ideas 2025 Report for Autonomous Trucking Leadership
SHANGHAI, Feb. 13, 2025 /PRNewswire/ — Inceptio Technology (“Inceptio” or the “Company”), an industry leading developer of autonomous driving technologies for heavy-duty trucks, today announced it was recognized in ARK Invest’s Big Ideas 2025 report as the undispu
Restore Vision Announces First Patient Dosed in Phase I/II Clinical Trial of RV-001 for Gene-Agnostic Retinitis Pigmentosa
The first optogenetic “Chimeric Rhodopsin” gene therapy tested in humans. RV-001 starting dose was generally well tolerated in this open-label trial. RV-001 a gene-agnostic approach for RP patients. TOKYO, Feb. 13, 2025 /PRNewswire/ — Restore Vision Inc., a clinical-stage biotechn
AXA Global Business Services Embarks on a New Era of Transformation as it Celebrates 30 Years in India
AXA GBS marks three decades in India, expanding across Bangalore, Pune, UK, and Morocco. It serves over 35 AXA entities in 14 countries, delivering innovation, operational excellence and high customer satisfaction, and has an employee footprint of over 4,000 employees globally. AXA GBS is transition
Kojamo plc’s Financial Statements and Board of Directors’ Report 2024 have been published
Kojamo plc Stock Exchange Release, 13 February 2025 at 8:30 a.m. EET HELSINKI, Feb. 13, 2025 /PRNewswire/ — Kojamo plc’s Financial Statements and Board of Directors’ Report 2024 have been published today. The Financial Statements includes the consolidated financial statements, the
